Skip to content

Public FDA record

Z-1968-2020: BD Alaris PCEA Administration Set, Microbore Tubing with Yellow Identification Stripe ASV, Catalog Number

Recall record Z-1968-2020 for BD SWITZERLAND SARL. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1968-2020
Company in FDA record
BD SWITZERLAND SARL
FDA record creation date
May 13, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

The products have the potential to leak between the connection of the male luer and the yellow striped tubing. This leak may be observed while priming or during use. The most likely health consequence associated with a leak in an administration set would be inadequate pain control for the patient due to an under-infusion of medication.

Source facts

Action
URGENT MEDICAL DEVICE RECALL BD Alaris PCEA Administration Set and BD Alaris PCEA Administration Kit letters dated 4/9/20 were distributed to customers. Please Take the Following Actions: 1. Immediately review your inventory for the Catalog and Lot Numbers specified in this notification and discard all product subject to the recall. 2. Share this recall notification with any users of the product, within your facilities, to ensure they are also aware of this recall. 3. As a direct replacement will not be available for the foreseeable future, complete the attached Customer Response Form and return to the BD contact noted on the form. Please indicate whether you have any of the impacted product so that BD may acknowledge your receipt of this notification and process your credit. 4. Report any adverse health consequences experienced with the use of this product to BD. Events may also be reported to the FDA's MedWatch Adverse Event Reporting program via: Web: MedWatch website at www.fda.gov/medwatch Phone: 1-800-FDA-1088 (1-800-332-1088) Mail: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787 Distributor Notice Please Take the Following Actions: 1. Immediately review your inventory for the Catalog and Lot Numbers specified in this notification and return all product subject to the recall to BD following the Packing Instructions enclosed. 2. Identify all your customers that purchased any affected product, as defined in this recall notification. Email an excel file listing of all customers to BDRC4@bd.com within 72 hours of receipt of this letter so that BD may notify customers directly. 3. Complete the attached Distributor Response Form and return to the BD contact noted on the form whether you have any of the impacted product so that BD may acknowledge your receipt of this notification and process your credit accordingly. 4. A copy of the customer communication is attached for your reference. Actions to be taken by BD: 1. BD will prov
Initiated
2020-04-09
Root cause
Under Investigation by firm
Terminated
2020-11-02
Distribution
Worldwide distribution - US Nationwide Distribution and the countries of Canada, Belgium.
Recall number
Z-1968-2020
Recall status
Terminated
CDRH record ID
181148
FDA record created
2020-05-13
Recall event number
85525

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗